The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-13), Flora Growth's share price is $1.37. Flora Growth's Book Value per Share for the quarter that ended in Dec. 2023 was $0.72. Hence, Flora Growth's PB Ratio of today is 1.91.
The historical rank and industry rank for Flora Growth's PB Ratio or its related term are showing as below:
FLGC'
s PB Ratio Range Over the Past 10 Years
Min: 0.32 Med: 1.04 Max: 29.88
Current: 1.91
During the past 5 years, Flora Growth's highest PB Ratio was 29.88. The lowest was 0.32. And the median was 1.04.
FLGC's PB Ratio is ranked better than 52.4% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2
vs FLGC: 1.91
During the past 12 months, Flora Growth's average Book Value Per Share Growth Rate was -91.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -54.80% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Flora Growth was -54.80% per year. The lowest was -54.80% per year. And the median was -54.80% per year.
Back to Basics: PB Ratio
Flora Growth PB Ratio Historical Data
The historical data trend for Flora Growth's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Flora Growth's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Flora Growth's PB Ratio distribution charts can be found below:
* The bar in red indicates where Flora Growth's PB Ratio falls into.
Flora Growth PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Flora Growth's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Flora Growth PB Ratio Related Terms
Thank you for viewing the detailed overview of Flora Growth's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company operates in the United States, Germany, Colombia, the United Kingdom, and Canada. it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FLGC has been successfully added to your 